GL1X · GenesisL1 explorer

MolNFT v1 · #169379 · protein

Crystal structure of the SARS-cov-2 (COVID-19) main protease in complex with UAW241

6XA4 · 3C-like proteinase: “Crystal structure of the SARS-cov-2 (COVID-19) main protease in complex with UAW241”. X-ray diffraction, 2 ligands (ACE, UXS), 3 pockets (best druggability 0.43). MolNFT v1 #169379 on GenesisL1: 3D structure…

PDB
6XA4
Type
protein
Length
306 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
3C-like proteinase; Inhibitor UAW241
EC
3.4.22.69
UniProt
P0DTD1
Ligands
ACE, UXS
Pockets
3 · best druggability 0.43

Structure

x-ray diffraction · 2 distinct chains · 26% helix, 28% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A3C-like proteinase (EC 3.4.22.69)protein30427% helix, 29% strandP0DTD1
BInhibitor UAW241protein20% helix, 0% strand—

Ligands and binding sites

  • ACE · Acetyl group · ligand · chains A, B
  • UXS · (2S)-2-amino-4-(methylsulfanyl)butan-1-ol · ligand · chains A, B
  • GOL · Glycerol · additive · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

3 pockets found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
1730.430.8118UXS
2890.330.7413empty
3600.310.7514empty

Interfaces

1 interface between chains.

  • A–B · 272 Ų buried · 2 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 3 covalent (covalent ligand).

Compared structures

  • 6XA4 · Crystal structure of the SARS-CoV-2 (COVID-19) main protease in complex with UAW241 · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.